Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,278) with videos related to
Page
of 128
Sort By:
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry
|
June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agents
Tao Wu, Advait Nagle, Kelli Kuhen, et al.
Nature Communications
|
June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Malina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 16, 2016
Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ
Adeline K Nicholas, Eva G Serra, Hakan Cangul, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 11, 2013
The IGSF1 deficiency syndrome: characteristics of male and female patients
S D Joustra, N Schoenmakers, L Persani, et al.
Nature Communications
|
October 18, 2018
Phenome-wide association studies across large population cohorts support drug target validation
Dorothée Diogo, Chao Tian, Christopher S Franklin, et al.
Science Translational Medicine
|
December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis
Srinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Antimicrobial Agents and Chemotherapy
|
June 11, 2014
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission
Kelli L Kuhen, Arnab K Chatterjee, Matthias Rottmann, et al.
Nature
|
November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malaria
Case W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.
Nature
|
July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13
Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Page
of 128
Search research articles
Search
Showing results (1091-1100 of 1,278) with videos related to
Sort By:
Page
of 128
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry
|
June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agents
Tao Wu, Advait Nagle, Kelli Kuhen, et al.
Nature Communications
|
June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Malina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 16, 2016
Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ
Adeline K Nicholas, Eva G Serra, Hakan Cangul, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 11, 2013
The IGSF1 deficiency syndrome: characteristics of male and female patients
S D Joustra, N Schoenmakers, L Persani, et al.
Nature Communications
|
October 18, 2018
Phenome-wide association studies across large population cohorts support drug target validation
Dorothée Diogo, Chao Tian, Christopher S Franklin, et al.
Science Translational Medicine
|
December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis
Srinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Antimicrobial Agents and Chemotherapy
|
June 11, 2014
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission
Kelli L Kuhen, Arnab K Chatterjee, Matthias Rottmann, et al.
Nature
|
November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malaria
Case W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.
Nature
|
July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13
Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Page
of 128